ALX Oncology Holdings Inc.
ALXO
$1.91
-$0.10-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.25% | 21.54% | -3.18% | 14.66% | 15.62% |
| Total Depreciation and Amortization | 276.00% | -0.66% | -1.31% | -78.57% | 238.39% |
| Total Amortization of Deferred Charges | -2.94% | -5.56% | 0.00% | 4.35% | 2.99% |
| Total Other Non-Cash Items | -71.42% | -7.16% | 7.55% | -45.21% | -4.57% |
| Change in Net Operating Assets | 114.11% | -592.15% | -65.21% | 166.96% | -591.78% |
| Cash from Operations | 13.89% | 1.75% | -11.04% | 26.97% | 5.10% |
| Capital Expenditure | 66.00% | -2.04% | 12.50% | -19.15% | 21.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.19% | -1,030.56% | -47.40% | -4.09% | -19.28% |
| Cash from Investing | 106.21% | -1,035.07% | -47.49% | -4.14% | -19.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.47% | -144.24% | -312.50% | 32.49% | 22.80% |
| Issuance of Common Stock | -99.93% | 684,777.27% | 2,100.00% | -93.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.94% | -819.30% | -- | -- | -100.00% |
| Cash from Financing | -99.90% | 20,489.23% | 526.42% | 28.38% | -441.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.06% | 325.08% | -270.75% | 415.55% | -143.06% |